Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
eXoZymes, Inc.
EXOZ · SEC Filings
website
32
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development ...
Price
4.275
Market Cap
39.82 M
Float
3.96 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about EXOZ
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
eXoZymes, Inc.
EXOZ · SEC Filings
3.96 M
Float
4.275
Price
39.82 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2025
News
TYPE
HEADLINE
FILED AT
8-K
eXoZymes Inc. Files Investor Presentation on Form 8-K
Oct 9, 2026
8-K
Exozymes Inc. Announces 2026 Annual Meeting Date and Related Timeline
Sep 18, 2026
8-K
eXoZymes Inc. Announces Closing of $639,990 Underwritten Unit Offering
Jul 1, 2026
8-K
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
Jun 25, 2026
8-K
eXoZymes Inc. Announces Closing of $6 Million Public Offering
Jun 17, 2026
8-K
eXoZymes, Inc. Announces Pricing of $5.33 Million Public Offering
Jun 8, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
REGISTERED OFFERING
Jun 30, 2026
424B5
REGISTERED OFFERING
Jun 8, 2026
424B5
PENDING FIXED PRICE OFFERING | Bank: MDB Capital
Jun 4, 2026
424B5
PENDING FIXED PRICE OFFERING | Bank: MDB Capital
May 29, 2026
424B5
PENDING FIXED PRICE OFFERING | Bank: MDB Capital
Apr 9, 2026
424B2
PENDING FIXED PRICE OFFERING | Offering amount: $50,000,000
Jan 26, 2026
Registrations
TYPE
HEADLINE
FILED AT
FWP
NEW
OFFERING
Nov 9, 2026
S-1
OFFERING
Nov 6, 2026
S-3
January 2026 SHELF
Jan 16, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 16, 2025
DRS
Form DRS - Draft Registration Statement
Dec 15, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 25, 2025
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Sep 28, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Sep 28, 2026
DEFR14A
Form DEFR14A - Revised definitive proxy soliciting materials
Jun 23, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Jun 20, 2025
Ownerships
TYPE
HEADLINE
FILED AT
4
Perriman Damien Alan (Reporting)
Oct 26, 2026
4/A
Korman Tyler Paz (Reporting)
Oct 21, 2026
4
Rayo Edgardo Javier (Reporting)
Oct 19, 2026
4
MARLETT CHRISTOPHER A (Reporting)
Oct 19, 2026
4
Lalonde James Joseph (Reporting)
Oct 19, 2026
4
DIGIANDOMENICO ANTHONY (Reporting)
Oct 19, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Jan 26, 2026
CORRESP
Form CORRESP - Correspondence
Jan 22, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Nov 12, 2024
CORRESP
Form CORRESP - Correspondence
Nov 6, 2024
CORRESP
Form CORRESP - Correspondence
Nov 6, 2024
CORRESP
Form CORRESP - Correspondence
Oct 31, 2024
